Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionMilestone Asset Management, Llc
Latest Disclosed Ownership8,166 shares
Latest Disclosed Value $ 1,138,095
Milestone Asset Management, Llc reports 83.19% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 15, 2026 - Milestone Asset Management, Llc filed a 13F-HR form disclosing ownership of 8,166 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,138,095 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 48,570 shares of Gilead Sciences, Inc.. This represents a change in shares of -83.19% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 8,166 -40,404 -83.19 1,138 -80.91 0.2098
2026-01-28 2025-12-31 13F GILEAD SCIENCES COM 375558103 48,570 29,548 155.34 5,962 182.38 1.1245
2025-10-15 2025-09-30 13F GILEAD SCIENCES COM 375558103 19,022 -577 -2.94 2,112 -2.81 0.3995
2025-08-05 2025-06-30 13F GILEAD SCIENCES COM 375558103 19,599 -40,744 -67.52 2,173 -67.87 0.4592
2025-04-09 2025-03-31 13F GILEAD SCIENCES COM 375558103 60,343 38,066 170.88 6,761 228.68 1.4391
2025-01-23 2024-12-31 13F GILEAD SCIENCES COM 375558103 22,277 7,513 50.89 2,058 66.29 0.4532
2024-10-25 2024-09-30 13F GILEAD SCIENCES COM 375558103 14,764 -7,413 -33.43 1,238 -18.67 0.2778
2024-07-19 2024-06-30 13F GILEAD SCIENCES COM 375558103 22,177 9,916 80.87 1,522 69.38 0.3809
2024-04-23 2024-03-31 13F GILEAD SCIENCES COM 375558103 12,261 12,261 898 0.2566
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.